136 related articles for article (PubMed ID: 15991530)
1. Dynamics of cervical langerhans cell counts in the course of HPV-positive CIN treatment with the use of human recombinant interferon gamma.
Sikorski M; Bieda T; Bobek M; Zrubek H
Eur J Gynaecol Oncol; 2005; 26(3):294-8. PubMed ID: 15991530
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection.
Sikorski M; Zrubek H
Eur J Gynaecol Oncol; 2003; 24(2):147-50. PubMed ID: 12701965
[TBL] [Abstract][Full Text] [Related]
4. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?
Barton SE; Maddox PH; Jenkins D; Edwards R; Cuzick J; Singer A
Lancet; 1988 Sep; 2(8612):652-4. PubMed ID: 2901519
[TBL] [Abstract][Full Text] [Related]
5. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
Hughes RG; Norval M; Howie SE
J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
7. Langerhans' cells and smoking in intraepithelial neoplasia of the cervix.
Nadais Rda F; Campaner AB; Piato S; Longo Galvão MA; dos Santos RE; Aoki T
Gynecol Oncol; 2006 Aug; 102(2):356-60. PubMed ID: 16472845
[TBL] [Abstract][Full Text] [Related]
8. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.
Mota F; Rayment N; Chong S; Singer A; Chain B
Clin Exp Immunol; 1999 Apr; 116(1):33-40. PubMed ID: 10209502
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096
[TBL] [Abstract][Full Text] [Related]
11. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
13. Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b.
Misson DR; Abdalla DR; Borges AM; Shimba DS; Adad SJ; Michelin MA; Murta EF
Tumori; 2011; 97(5):578-84. PubMed ID: 22158487
[TBL] [Abstract][Full Text] [Related]
14. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection.
Gonçalves MA; Soares EG; Fernandes AP; Fonseca BA; Bettini JS; Simões RT; Donadi EA
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):221-7. PubMed ID: 15140519
[TBL] [Abstract][Full Text] [Related]
15. [Iscador QuS and human recombinant interferon alpha (Intron A) in cervical intraepithelial neoplasia (CIN)].
Jach R; Basta A
Przegl Lek; 1999; 56(1):86-8. PubMed ID: 10375935
[TBL] [Abstract][Full Text] [Related]
16. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
Front Immunol; 2020; 11():612547. PubMed ID: 33552075
[TBL] [Abstract][Full Text] [Related]
17. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell density in cervical intraepithelial neoplasia associated with human papillomavirus infection in HIV-infected and HIV-noninfected Brazilian women.
Zimmermmann JB; Gobbi H; Alves MJ; Quirino MG; Melo VH
Int J Gynecol Cancer; 2012 Oct; 22(8):1291-6. PubMed ID: 22932260
[TBL] [Abstract][Full Text] [Related]
19. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia.
Ichimura H; Yamaguchi S; Kojima A; Tanaka T; Niiya K; Takemori M; Hasegawa K; Nishimura R
Int J Clin Oncol; 2003 Oct; 8(5):322-5. PubMed ID: 14586759
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.
Jimenez-Flores R; Mendez-Cruz R; Ojeda-Ortiz J; Muñoz-Molina R; Balderas-Carrillo O; de la Luz Diaz-Soberanes M; Lebecque S; Saeland S; Daneri-Navarro A; Garcia-Carranca A; Ullrich SE; Flores-Romo L
Immunology; 2006 Feb; 117(2):220-8. PubMed ID: 16423058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
